Technical variability across the 450K, EPICv1, and EPICv2 DNA methylation arrays: lessons learned for clinical and longitudinal studies.

Journal: Clinical epigenetics

Publication date: 2024

Journal: Clinical epigenetics

Publication Year: 2024

Authors & Co-authors:  Lussier Alexandre A AA Schuurmans Isabel K IK Großbach Anna A Maclsaac Julie J Dever Kristy K Koen Nastassja N Zar Heather J HJ Stein Dan J DJ Kobor Michael S MS Dunn Erin C EC

ENIGMA-Sleep: Challenges, opportunities, and the road map.

Journal: Journal of sleep research

Publication date: 2021

Journal: Journal of sleep research

Publication Year: 2021

Authors & Co-authors:  Tahmasian Masoud M Aleman André A Andreassen Ole A OA Arab Zahra Z Baillet Marion M Benedetti Francesco F Bresser Tom T Bright Joanna J Chee Michael W L MWL Chylinski Daphne D

DNA methylation and general psychopathology in childhood: an epigenome-wide meta-analysis from the PACE consortium.

Journal: Molecular psychiatry

Publication date: 2023

Journal: Molecular psychiatry

Publication Year: 2023

Authors & Co-authors:  Rijlaarsdam Jolien J Cosin-Tomas Marta M Schellhas Laura L Abrishamcar Sarina S Malmberg Anni A Neumann Alexander A Felix Janine F JF Sunyer Jordi J Gutzkow Kristine B KB Grazuleviciene Regina R

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.

Journal: Movement disorders : official journal of the Movement Disorder Society

Publication date: 2023

Journal: Movement disorders : official journal of the Movement Disorder Society

Publication Year: 2023

Authors & Co-authors:  Vollstedt Eva-Juliane EJ Schaake Susen S Lohmann Katja K Padmanabhan Shalini S Brice Alexis A Lesage Suzanne S Tesson Christelle C Vidailhet Marie M Wurster Isabel I Hentati Faycel F

Virtual Ontogeny of Cortical Growth Preceding Mental Illness.

Journal: Biological psychiatry

Publication date: 2022

Journal: Biological psychiatry

Publication Year: 2022

Authors & Co-authors:  Patel Shin Abé Agartz Alloza Alnæs Ambrogi Antonucci Arango Arolt

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).

Journal: American journal of clinical dermatology

Publication date: 

Journal: American journal of clinical dermatology

Publication Year: 

Authors & Co-authors:  Silverberg Gooderham Paller Deleuran Bunick Gold Hijnen Calimlim Lee Teixeira